Shenzhen Chipscreen Biosciences Co (SHSE:688321) Net Income From Continuing Operations : ¥-115.4 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Shenzhen Chipscreen Biosciences Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Shenzhen Chipscreen Biosciences Co's net income from continuing operations for the three months ended in Mar. 2025 was ¥-19.2 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-115.4 Mil.

Shenzhen Chipscreen Biosciences Co Net Income From Continuing Operations Historical Data

The historical data trend for Shenzhen Chipscreen Biosciences Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Chipscreen Biosciences Co Net Income From Continuing Operations Chart

Shenzhen Chipscreen Biosciences Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

31.05

21.96

12.82

49.19

-114.57

Shenzhen Chipscreen Biosciences Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															-18.31	-22.70	-10.08	-63.49	-19.16

Shenzhen Chipscreen Biosciences Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-115.4 Mil.

Shenzhen Chipscreen Biosciences Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Chipscreen Biosciences Co Ltd (SHSE:688321) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

N/A

Address

No. 10, Gaoxin Zhongyi, Room 601-606, Building 2, Shenzhen Biological Incubation Base, Gaoxin Zhongyi, Nanshan District, Guangdong, Shenzhen, CHN, 518057

Website

http://www.chipscreen.com

Shenzhen Chipscreen Biosciences Co Ltd is engaged in the research and development of small molecule drugs.

Executives

Shan Song	Core technical personnel
Xie Zheng Sheng	Supervisors
She Liang Ji	senior management
Hai Ou	Directors, senior managers
Pan De Si	Senior management, core technical personnel
Zhang Li Bin	senior management
Li Jian Xun	Director
Li Zhi Bin	senior management
Ning Zhi Qiang	senior management
Zhao Shu Mei	Director
Shen Jian Hua	Supervisors

Shenzhen Chipscreen Biosciences Co Headlines

No Headlines